RAPLIXASPRAY

Welcome to the Brand page for “RAPLIXASPRAY”, which is offered here for Hemostatics for medical purposes; hemostatic pharmaceutical preparations, a blood clotting aid and delivery system for use in human and veterinary medicine; platelet additive solution for medical and clinical use in storing blood components; solutions for medical and clinical use in storing and treating cell tissue; solutions for medical and clinical use in storing and treating blood and blood components; dry powder hemostatic pharmaceutical preparations, a blood clotting aid and delivery system for use in surgery; hemostatic gel matrix preparations for treating wounds; hemostatic gel matrix preparations for treating traumatic wounds and burns; hemostatic gel matrix preparations for treating surgical wound during surgery; apparatus for delivery of hemostatic substances, aerosol dispensers for medical use sold filled with hemostatic preparations; apparatus for delivery of hemostatic substances, aerosol dispensers for medical use during surgery sold filled with hemostatic preparations; apparatus for delivery of hemostatic substances, aerosol dispensers for medical use sold filled with dry hemostatic preparations; apparatus for delivery of hemostatic substances, aerosol dispensers sold filled with hemostatic preparations for medical use during surgery to treat wounds; apparatus for delivery of hemostatic substances, aerosol dispensers sold filled with hemostatic preparations for medical use during surgery to treat traumatic wounds and burns; apparatus for delivery of hemostatic substances, aerosol dispensers sold filled with hemostatic preparations for medical use during surgery to treat surgical wounds;raplixa spray;.

Its status is currently believed to be active. Its class is unavailable. “RAPLIXASPRAY” is believed to be currently owned by “ProFibrix B.V.”